Moneycontrol

You are Here : DRL Q3 EBITDA seen up 103% to Rs 596 cr

Friday, 08:00

Pharmaceutial firm Dr Reddy's Laboratories is expected to report a profit after tax of Rs 425 crore in the third quarter of FY12, a massive growth of 55.5% as compared to Rs 273 crore in a year ago quarter.
MAY 27, 2017
07:26 PM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On